MoneyWorks4Me

Solara Active Pharma Sciences informs about disclosure

30 Aug 2024 Evaluate
Solara Active Pharma Sciences has informed that it enclosed revised Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on August 29, 2024 for Pronomz Ventures LLP.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1760.60
Dr. Reddys Labs. 1220.75
Cipla 1333.70
Lupin 1959.20
Zydus Lifesciences 1140.75
View more..